The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study.
The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study.
复制标题
糖尿病患者的心力衰竭和基于人群的研究。
DOI:
10.1016/j.jacc.2009.12.003
复制
发表时间:
2010-01-26
影响因子:
24
通讯作者:
Chen, Horng H.
中科院分区:
文献类型:
--
作者:
From, Aaron M.;Scott, Christopher G.;Chen, Horng H.
Evaluate the outcomes of preclinical diastolic dysfunction in diabetic patients Studies have reported a high prevalence of preclinical diastolic dysfunction among patients with diabetes mellitus. We identified all diabetic patients with a tissue Doppler assessment of diastolic function in Olmsted County, MN from 2001 to 2007. Diastolic dysfunction was defined as a Doppler mitral E/e′ ratio >15. The main outcome was the development of heart failure (HF). Secondary outcomes were the development of atrial fibrillation and death. Overall, 1,760 diabetic patients with a tissue Doppler echocardiographic assessment of diastolic function were identified; 411 patients (23%) had diastolic dysfunction. Using multivariable Cox's proportional hazard modeling, we determined that for every 1 unit increase in the mitral E/e′ ratio, the hazard of HF increased by 3% (HR=1.03, 95% CI=1.01-1.06; p=0.006) and that diastolic dysfunction was associated with the subsequent development of HF after adjustment for age, sex, body mass index, hypertension, coronary disease and echocardiographic parameters (HR=1.61, 95% CI=1.17-2.20; p=0.003). The cumulative probability of the development of HF at 5 years for diabetic patients with diastolic dysfunction was 36.9% compared to 16.8% for patients without diastolic dysfunction (P<0.001). Furthermore, diabetic patients with diastolic dysfunction had a significantly higher mortality compared to those without diastolic dysfunction. We demonstrated that an increase in the E/e′ ratio in diabetic patients is associated with the subsequent development of HF and increased mortality independent of hypertension, coronary disease or other echocardiographic parameters.
登录
查看更多内容
影响因子:
2.8
作者:
From, Aaron M.;Scott, Christopher G.;Chen, Horng H.
通讯作者:
Chen, Horng H.
影响因子:
16.2
作者:
Poirier, P;Bogaty, P;Dumesnil, JG
通讯作者:
Dumesnil, JG
影响因子:
120.7
作者:
Redfield, MM;Jacobsen, SJ;Rodeheffer, RJ
通讯作者:
Rodeheffer, RJ
影响因子:
24
作者:
Galderisi, Maurizio
通讯作者:
Galderisi, Maurizio
影响因子:
4.8
作者:
Lee, M;Gardin, JM;Ward, BJ
通讯作者:
Ward, BJ